逾170名德勤职员透过外展服务接种新冠疫苗
外展接种服务队为超过170名德勤职员接种复必泰疫苗,是第一间参与计划的公司。
公务员事务局局长聂德权今日(18日)到访德勤,与德勤中国华南区主管合夥人欧振兴及资深顾问陈清霞博士一同视察企业职员透过外展服务接种新冠疫苗的情况。
聂德权表示,国际专业服务企业职员经常要到海外工作和参加会议,但海外的新冠疫情仍然严重。因此接种疫苗十分重要,既能保障职员的健康,亦让企业可以正常运作。政府现时正与建造业界、顾问公司、公用事业机构等商讨及推行外展接种服务,呼吁不同界别和行业的相关企业和团体鼓励员工踊跃接种疫苗。
德勤中国华南区主管合夥人欧振兴表示,上月初曾谘询约200位同事的意见,他们对接种复必泰疫苗较有兴趣,便开始和政府沟通疫苗接种安排。同事接种疫苗後可回家休息,并在6月11日再接种第二剂疫苗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.